Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Ryst E, Ive P, Mohapi L, Mingrone H, Horban A, Hackman F, Sullivan J, Mayer H.
Cooper DA, et al. Among authors: ive p.
J Infect Dis. 2010 Mar 15;201(6):803-13. doi: 10.1086/650697.
J Infect Dis. 2010.
PMID: 20151839
Clinical Trial.